Literature DB >> 2602648

Preliminary results of autologous bone marrow transplantation in the management of resistant Hodgkin's disease: experience of the Bloomsbury Transplant Group at University College, London.

J G Gribben1, A H Goldstone, D C Linch.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2602648     DOI： 10.1007/978-3-642-83781-4_27

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  1 in total

1.  Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.

Authors:  L K Seymour; R D Dansey; W R Bezwoda
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.